Product image of Бортезомиб Актавис (Bortezomib) supplied by GNH India

Бортезомиб Актавис

Active Ingredient:
Bortezomib
Origin:
EU

Бортезомиб Актавис (Bortezomib)

Бортезомиб Актавис is an injectable proteasome inhibitor used in cancer therapy. This EU-manufactured medication targets malignant cells by disrupting protein breakdown. Suitable for patients requiring targeted chemotherapy. Short version: Bortezomib injection for targeted cancer treatment, EU-sourced.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Bortezomib is primarily used to treat multiple myeloma and mantle cell lymphoma by slowing or stopping cancer cell growth. It is often prescribed when other treatments have not been effective. Patients may also receive it as part of combination therapy for improved outcomes. This medication belongs to a class of drugs that interfere with cancer cell survival mechanisms.

Side Effects

  • Bortezomib works by blocking proteasomes, which are structures in cells that break down proteins. By inhibiting this process, abnormal proteins accumulate in cancer cells, leading to cell death. Patients may experience changes in energy levels or appetite as the body adjusts to the medication. These effects are part of the intended therapeutic action.

Precautions & Warnings

  • Bortezomib should be administered under medical supervision in a clinical setting. Patients with pre-existing liver, kidney, or heart conditions require careful monitoring during treatment. Regular blood tests help track white blood cell counts and other health indicators. Avoid exposure to infections and report any unusual symptoms immediately.

Avoid Interactions

  • Bortezomib may interact with medications that affect liver enzymes, such as certain antifungals or antibiotics. Combining it with other chemotherapy drugs or blood pressure medications can increase side effects. Alcohol and grapefruit products may also influence how the drug works. Always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

Bortezomib is used to treat multiple myeloma and mantle cell lymphoma by targeting cancer cells.

Bortezomib is given as an intravenous injection in a healthcare setting.

Common side effects may include fatigue, nausea, or changes in blood cell counts.

Consult your doctor before combining Bortezomib with other drugs to avoid interactions.

Bortezomib may harm unborn babies; discuss risks with a healthcare provider if pregnant or planning pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bortezomib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT